Search results
-
ASCO 2025 – Astra seeks a new SERD paradigm
ASCO 2025 – Astra seeks a new SERD paradigm …
- 06/02/2025 - 14:04 -
ASCO 2025 – Enhertu mounts its first-line charge
ASCO 2025 – Enhertu mounts its first-line charge … HR=0.56; p<0.00001 HR=0.62, p<0.0001 Source: ASCO 2025, Perjeta label. Discussing the results at …
- 06/04/2025 - 14:52 -
ASCO 2025 – Trodelvy heads for the front line
ASCO 2025 – Trodelvy heads for the front line … 31% TEAE-related death 3% 3% Source: ASCO 2025. Ascent-04 also saw an “early trend” …
- 06/01/2025 - 21:07 -
ASCO 2025 – vepdegestrant matches rival degraders
ASCO 2025 – vepdegestrant matches rival degraders …
- 06/01/2025 - 21:07 -
ASCO 2025 – Braftovi breaks new ground
ASCO 2025 – Braftovi breaks new ground …
- 05/31/2025 - 14:02 -
ASCO 2025 preview – KRAS challengers assemble
ASCO 2025 preview – KRAS challengers assemble … when their titles were revealed . Selected ASCO 2025 regular presentations for small molecules …
- 05/28/2025 - 10:07 -
ASCO 2025 preview – Kura looks similar to Syndax
ASCO 2025 preview – Kura looks similar to Syndax … differentiation syndrome 13% 13% Source ASCO 2025 abstract Nov 2024 PR Regulatory status …
- 05/28/2025 - 16:41 -
ASCO 2025 preview – patritumab hangs in the balance
ASCO 2025 preview – patritumab hangs in the balance … rate, which was no worse than for 2mg/kg. ASCO 2025 regular presentations covering selected ADCs …
- 05/28/2025 - 22:29 -
Trodelvy trumps Datroway again
… for PFS in Apr 2025; trend to OS improvement; full data at ASCO 2025 Tropion-Breast05 , data due 2026 …
- 05/27/2025 - 14:58 -
ASCO 2025 preview – Merus tops Bicara
ASCO 2025 preview – Merus tops Bicara … EGFR epitope 806 and IL13Rα2. Selected ASCO 2025 regular presentations for biologicals, excluding …
- 05/27/2025 - 14:36
